Clinical applications of immunohistochemistry in gynecological malignancies

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 311-315

  Shutter, J ^a   Atkins, K A ^b   Ghartey, K ^c   Herzog, T J ^d  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d Howard Hughes Medical Institute   (United States)

Author keywords

Gynecological malignancies; Immunohistochemistry; Pathology

Indexed keywords

EOSIN; HEMATOXYLIN;

ANTIBODY RESPONSE; COLON CARCINOMA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; EVALUATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MESOTHELIOMA; MICROSCOPY; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW;

CARCINOMA; COST-BENEFIT ANALYSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; NEOPLASMS, UNKNOWN PRIMARY;

EID: 33947287895     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00759.x     Document Type: Review

References (9)

1. Daabs D. Diagnostic Immunohistochemistry. Philadelphia, PA: Churchill Livingston, 2002.
2. Raab S. The cost-effectiveness of immunohistochemistry. Arch Pathol Lab Med 2000;124:1185-91.
3. Kurman RJ., ed. Blaustein's pathology of the female genital tract, 5th edn. New York: Springer, 2002.
4. Ordonez N. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 1998;22:1203-14.
5. Dabbs D, Sturtz K, Zaino R. The immunohistochemical discrimination of endometrioid adenocarcinoma. Hum Pathol 1996;27:172-7.
6. Agoff S, Grieco V, Garcia R et al. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 2001;9:164-9.
7. Klaes R, Friedrich T, Sptikovsky D et al. Overexpression of p16 as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
8. Stoler M, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-05.
9. Klaes R, Benner A, Friedrich T et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389- 99.